GT
EXPO icon

Glenmede Trust’s Exponent EXPO Stock Holding History

Glenmede Trust’s Portfolio EXPO Stock Details EXPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$525K Sell
8,053
-2,290
-22% -$163K ﹤0.01% 947
2025
Q4 		$718K Buy
+10,343
New +$727K ﹤0.01% 830
2025
Q1 		$965K Sell
11,900
-1,062
-8% -$92.5K 0.01% 712
2024
Q4 		$1.15M Sell
12,962
-694
-5% -$69.9K 0.01% 675
2024
Q3 		$1.57M Sell
13,656
-278
-2% -$29.1K 0.01% 620
2024
Q2 		$1.33M Buy
13,934
+103
+0.7% +$9.29K 0.01% 635
2024
Q1 		$1.14M Buy
13,831
+2,067
+18% +$171K 0.01% 677
2023
Q4 		$1.04M Sell
11,764
-14
-0.1% -$1.15K 0.01% 680
2023
Q3 		$1.01M Sell
11,778
-576
-5% -$52.1K 0.01% 654
2023
Q2 		$1.23M Hold
12,354
– – 0.01% 611
2023
Q1 		$1.23M Sell
12,354
-299
-2% -$30.4K 0.01% 612
2022
Q4 		$1.25M Buy
12,653
+33
+0.3% +$3.21K 0.01% 607
2022
Q3 		$1.11M Sell
12,620
-730
-5% -$69.2K 0.01% 628
2022
Q2 		$1.22M Sell
13,350
-1,500
-10% -$141K 0.01% 622
2022
Q1 		$1.6M Sell
14,850
-10,177
-41% -$982K 0.01% 589
2021
Q4 		$2.92M Buy
25,027
+1,148
+5% +$135K 0.01% 496
2021
Q3 		$2.7M Buy
23,879
+200
+0.8% +$21.6K 0.01% 492
2021
Q2 		$2.11M Buy
23,679
+60
+0.3% +$5.62K 0.01% 527
2021
Q1 		$2.3M Buy
23,619
+2,141
+10% +$201K 0.01% 500
2020
Q4 		$1.93M Buy
21,478
+3,272
+18% +$261K 0.01% 528
2020
Q3 		$1.31M Buy
18,206
+2,789
+18% +$222K 0.01% 562
2020
Q2 		$1.25M Sell
15,417
-2,687
-15% -$193K 0.01% 565
2020
Q1 		$1.25M Hold
18,104
– – 0.01% 707
2019
Q4 		$1.25M Sell
18,104
-494
-3% -$32.6K 0.01% 707
2019
Q3 		$1.3K Buy
18,598
+3,694
+25% +$249K 0.01% 685
2019
Q2 		$872 Buy
14,904
+5,189
+53% +$295K ﹤0.01% 772
2019
Q1 		$560 Sell
9,715
-33,861
-78% -$1.83M ﹤0.01% 868
2018
Q4 		$2.21K Buy
43,576
+32,947
+310% +$1.65M 0.01% 603
2018
Q3 		$569K Sell
10,629
-1,049
-9% -$53.7K ﹤0.01% 866
2018
Q2 		$564K Sell
11,678
-784
-6% -$36K ﹤0.01% 805
2018
Q1 		$442K Hold
12,462
– – ﹤0.01% 950
2017
Q4 		$442K Buy
12,462
+198
+2% +$7.27K ﹤0.01% 950
2017
Q3 		$453K Sell
12,264
-200
-2% -$6.61K ﹤0.01% 934
2017
Q2 		$370K Hold
12,464
– – ﹤0.01% 1013
2017
Q1 		$370K Sell
12,464
-70
-0.6% -$2.04K ﹤0.01% 1013
2016
Q4 		$377K Hold
12,534
– – ﹤0.01% 1027
2016
Q3 		$319K Sell
12,534
-200
-2% -$5.21K ﹤0.01% 1060
2016
Q2 		$371K Buy
12,734
+100
+0.8% +$2.6K ﹤0.01% 1010
2016
Q1 		$322K Sell
12,634
-1,056
-8% -$25.5K ﹤0.01% 1031
2015
Q4 		$341K Sell
13,690
-276
-2% -$7K ﹤0.01% 1039
2015
Q3 		$311K Sell
13,966
-5,206
-27% -$115K ﹤0.01% 1080
2015
Q2 		$428K Sell
19,172
-2,400
-11% -$52.7K ﹤0.01% 1005
2015
Q1 		$477K Sell
21,572
-5,920
-22% -$127K ﹤0.01% 974
2014
Q4 		$566K Hold
27,492
– – ﹤0.01% 884
2014
Q3 		$485K Buy
27,492
+12,800
+87% +$235K ﹤0.01% 879
2014
Q2 		$271K Sell
14,692
-652
-4% -$11.6K ﹤0.01% 1066
2014
Q1 		$287K Buy
15,344
+2,400
+19% +$44.3K ﹤0.01% 1064
2013
Q4 		$249K Hold
12,944
– – ﹤0.01% 1075
2013
Q3 		$231K Hold
12,944
– – ﹤0.01% 1078
2013
Q2 		$190K Buy
+12,944
New +$178K ﹤0.01% 1094

Other funds holding EXPO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Glenmede Trust's EXPO Position: Q1 2026 in Review

Glenmede Trust reduced its Exponent (EXPO) stake by 22% in Q1 2026, selling an estimated $163K and leaving 8,053 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #947.

Glenmede Trust first reported a position in EXPO in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.92M in Q4 2021. 360 funds tracked by Wall St. Rank hold EXPO as of Q1 2026.

  • Glenmede Trust held 8,053 shares of Exponent worth $525K as of Q1 2026.
  • Glenmede Trust sold 2,290 Exponent shares in Q1 2026, an estimated $163K.
  • Exponent made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #947 holding.
  • Glenmede Trust first reported a position in Exponent in Q2 2013 and has held it in 50 quarters since.
  • Glenmede Trust's Exponent position peaked at $2.92M in Q4 2021.
  • 360 funds tracked by Wall St. Rank held Exponent as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.